Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-7.54 Insider Own4.41% Shs Outstand1.42M Perf Week-6.62%
Market Cap8.82M Forward P/E15.92 EPS next Y0.39 Insider Trans0.00% Shs Float1.36M Perf Month-5.05%
Income-9.07M PEG- EPS next Q-0.93 Inst Own10.45% Short Float0.68% Perf Quarter-12.60%
Sales13.26M P/S0.67 EPS this Y42.13% Inst Trans-17.43% Short Ratio1.29 Perf Half Y-18.50%
Book/sh9.37 P/B0.66 EPS next Y106.24% ROA-42.57% Short Interest0.01M Perf Year-63.90%
Cash/sh1.10 P/C5.65 EPS next 5Y20.00% ROE-58.25% 52W Range4.75 - 17.60 Perf YTD-4.46%
Dividend Est.- P/FCF- EPS past 5Y65.35% ROI-67.00% 52W High-64.72% Beta1.61
Dividend TTM- Quick Ratio0.67 Sales past 5Y38.91% Gross Margin31.91% 52W Low30.70% ATR (14)0.40
Dividend Ex-Date- Current Ratio0.79 EPS Y/Y TTM29.27% Oper. Margin-68.57% RSI (14)46.20 Volatility2.64% 5.62%
Employees55 Debt/Eq0.10 Sales Y/Y TTM40.22% Profit Margin-68.39% Recom1.00 Target Price19.00
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q62.64% Payout- Rel Volume0.04 Prev Close6.34
Sales Surprise2.68% EPS Surprise14.05% Sales Q/Q103.97% EarningsNov 20 BMO Avg Volume7.19K Price6.21
SMA20-3.11% SMA50-2.18% SMA200-17.38% Trades Volume288 Change-2.10%
Feb-13-24 10:00AM
Feb-06-24 10:00AM
Jan-23-24 10:00AM
Jan-17-24 10:30AM
Jan-02-24 09:00AM
04:30PM Loading…
Dec-14-23 04:30PM
Nov-16-23 05:00PM
Oct-18-23 09:00AM
Oct-03-23 10:00AM
Sep-28-23 09:00AM
Sep-25-23 11:00AM
Sep-21-23 09:00AM
Sep-13-23 09:30AM
Aug-31-23 03:26PM
Aug-19-23 06:01AM
10:16AM Loading…
Aug-13-23 10:16AM
Aug-10-23 05:00PM
Aug-08-23 09:00AM
Aug-03-23 09:00AM
Aug-01-23 09:00AM
Jun-14-23 09:49AM
Jun-13-23 09:00AM
Jun-08-23 08:30AM
Jun-07-23 09:30AM
May-22-23 11:00AM
May-17-23 04:00PM
May-15-23 04:00PM
May-04-23 01:00PM
Apr-27-23 05:00PM
11:00AM Loading…
Apr-19-23 11:00AM
Apr-09-23 10:25AM
Apr-02-23 08:55AM
Mar-28-23 05:00PM
Mar-21-23 10:30AM
Mar-07-23 12:49PM
Feb-14-23 11:44AM
Jan-11-23 10:00AM
Dec-06-22 10:00AM
Nov-07-22 10:30AM
Nov-02-22 05:00PM
Oct-18-22 09:07AM
Sep-15-22 11:00AM
Aug-24-22 11:00AM
Aug-16-22 11:00AM
Aug-10-22 10:00AM
Aug-08-22 10:00AM
Jul-20-22 10:30AM
Jun-14-22 02:00PM
Jun-13-22 11:00AM
May-24-22 10:30AM
May-11-22 08:15AM
May-10-22 10:30AM
Apr-26-22 10:00AM
Mar-22-22 06:00PM
Mar-21-22 05:00PM
Feb-24-22 10:00AM
Nov-29-21 07:27AM
Nov-18-21 10:00AM
Nov-03-21 08:00AM
Nov-01-21 05:00PM
Aug-26-21 10:00AM
Aug-20-21 05:00PM
Aug-13-21 10:48AM
Aug-12-21 05:00PM
Jul-28-21 10:00AM
Jun-15-21 11:00AM
Jun-08-21 10:30AM
May-20-21 03:15PM
May-14-21 04:30PM
May-10-21 10:30AM
May-05-21 10:14AM
May-04-21 02:41PM
May-03-21 10:41AM
Apr-26-21 11:00AM
Apr-05-21 09:00AM
Mar-31-21 03:15PM
Mar-30-21 09:00AM
Mar-18-21 04:30PM
Mar-03-21 01:00PM
Jan-28-21 09:30AM
Jan-20-21 10:00AM
Dec-10-20 10:15AM
Nov-19-20 03:15PM
Nov-11-20 09:00AM
Oct-06-20 10:00AM
Sep-22-20 10:30AM
Sep-04-20 09:00AM
Aug-20-20 01:00PM
Aug-07-20 09:00AM
Aug-04-20 10:45AM
Jul-31-20 07:45AM
Jul-30-20 10:15AM
Precipio, a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.